Evidence supporting the use of: Echinacea pallida
For the health condition: Infection (viral)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Echinacea pallida, commonly known as pale purple coneflower, has a long history of traditional use among Native American tribes and in herbal medicine for treating various infections, including those thought to be of viral origin, such as the common cold. The traditional justification stems from the broader use of Echinacea species, including E. angustifolia and E. purpurea, for respiratory and general infections. While E. pallida is less commonly studied than other species, some traditional remedies have included its roots or aerial parts in decoctions and teas aimed at enhancing immune response and mitigating infection symptoms.

Scientific validation for E. pallida specifically in treating viral infections is limited. Most clinical and preclinical studies focus on E. purpurea, with some evidence suggesting modest benefits in reducing the duration or severity of upper respiratory tract infections. However, E. pallida shares some phytochemical constituents, such as alkamides and caffeic acid derivatives, which are thought to have immunomodulatory effects. Despite this, direct clinical evidence for E. pallida’s efficacy against viral infections is lacking. Thus, its use is primarily justified by traditional practices, with a low to moderate level of indirect scientific support based on related species and shared compounds.

In summary, Echinacea pallida’s use for viral infection is rooted in tradition, with insufficient direct scientific evidence to strongly support its efficacy. More research specific to this species is needed to clarify its potential benefits.

More about Echinacea pallida
More about Infection (viral)

Products containing Echinacea pallida

We currently have no products on Vitabase that contain this ingredient.